
Dana Devine

Dana Devine is a blood transfusion researcher and the president-elect of AABB. She was the editor-in-chief of "Vox Sanguinis" from 2012 to 2020. Devine is also the Chief Scientist at Canadian Blood Services and the director of the Centre for Blood Research at University of British Columbia. In 2015, she was elected as a fellow of the Canadian Academy of Health Sciences.
Education.
Devine received her PhD in immunology from Duke University in 1986. She previously completed a bachelor's degree in biology and a master's degree in marine biology, both at Boston University.
Research and career.
Devine first joined Canadian Blood Services (CBS) in 1999, following its creation as a result of the Krever Inquiry, as the executive director of research and development. She was vice-president of medical, scientific, and research affairs for 11 years before becoming Chief Scientist. Her work at CBS has included improvements to testing for transfusion transmitted infection and improvements to platelet unit manufacturing processes. Also in response to the Krever Inquiry, Devine co-founded the Centre for Blood Research in 2002. In 2021, she became its director. Devine was elected president of AABB in 2020, to take office in October 2021. She was previously a vice-president of AABB.
For her "critical scientific leadership to Canada’s blood system," Devine was elected a fellow of the Canadian Academy of Health Sciences in 2015.
Devine has been a professor in the University of British Columbia's Department of Pathology and Laboratory Medicine since 2000, where she is also the Graduate Studies Program Director.
Devine's research specialties are in blood system management and quality improvement, platelet biology and coagulation, and complement biochemistry. She is an executive member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, where her projects focus on improving the processing, quality, and utilization of conventional blood components. Her laboratory at the University of British Columbia is focused on improving the storage quality of platelet units. Devine is also involved in research on the use of convalescent plasma to treat COVID-19, as well as research using Raman spectroscopy to assess the quality of stored red blood cells.